Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
5Y CAGR+47.9%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+47.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
7.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.65B | +109.4% |
| 2024 | $789.20M | +628.6% |
| 2023 | $-149.30M | +71.7% |
| 2022 | $-526.80M | -239.0% |
| 2021 | $379.00M | +62.1% |
| 2020 | $233.80M | +6.6% |
| 2019 | $219.30M | +1048.2% |
| 2018 | $19.10M | +1868.5% |
| 2017 | $-1.08M | -16.6% |
| 2016 | $-926000.00 | - |